Lawrenceville, NJ, United States of America

Janak Singh

USPTO Granted Patents = 28 (Patent Applications = 1)

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 210(Granted Patents)

Location History:

Lawrenceville, NJ (US) (1990 - 2011)
Princeton, NJ (US) (2013 - 2016)

Company Filing History:

13 out of 3,681

Bristol-myers Squibb Compnay

patents

13 out of 1,624

E. R. Squibb Sons, Inc.

Years Active: 1990-2016

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9453039 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2016-09-27),

2. 8501698 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2013-08-06),

3. 7932379 - Methods of producing C-aryl glucoside SGLT2 inhibitors (2011-04-26),

4. 7919598 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2011-04-05),

5. 7375213 - Methods of producing C-aryl glucoside SGLT2 inhibitors (2008-05-20),

6. 6087383 - Bisulfate salt of HIV protease inhibitor (2000-07-11),

7. 5874578 - Process for preparing guanine-containing antiviral agents and purinyl (1999-02-23),

8. 5618946 - 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates (1997-04-08),

9. 5608064 - Purinyl salts useful for preparing guanine containing antiviral agents (1997-03-04),

10. 5539130 - 7-Oxabicycloheotane carboxylic acid prostaglandin analog intermediates (1996-07-23),

11. 5539126 - Method for preparing homochiral maleimide intermediates, via silylation (1996-07-23),

12. 5525726 - Process for the preparation of an antiviral agent (1996-06-11),

13. 5516903 - Process for preparing (1996-05-14),

14. 5512690 - 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates (1996-04-30),

15. 5508445 - 7-oxabicycloheptane carboxylic acid protaglandin analog intermediates (1996-04-16),

Title: Janak Singh: A Trailblazer in Pharmaceutical Innovations

Introduction: Janak Singh, located in Lawrenceville, NJ, is a prolific inventor with an impressive portfolio of 28 patents. His contributions to the field of pharmaceuticals, particularly in the development of SGLT2 inhibitors, have significantly advanced treatments for diabetes and other related diseases.

Latest Patents: Among his latest innovations, Janak has developed crystal structures of SGLT2 inhibitors. These patents detail the physical crystal structures of a compound defined by the formula I, where specific groups are designated as R. The inventions cover pharmaceutical compositions containing these structures, processes for preparing them, intermediates used in their synthesis, and methodologies for treating diseases such as diabetes.

Career Highlights: Janak Singh has had a distinguished career, with significant contributions stemming from his time at renowned companies like Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. His work has not only added to the pharmaceutical landscape but also helped in the formulation of effective treatments that impact patient health positively.

Collaborations: Throughout his career, Janak has collaborated with notable professionals such as Richard H. Mueller and Jollie D. Godfrey, Jr. These partnerships have played a vital role in the development of innovative pharmaceutical solutions, demonstrating the importance of teamwork in the field of research and invention.

Conclusion: Janak Singh stands out as a leading inventor in the pharmaceutical industry, with a focus on enhancing therapies for diabetes through his innovative patents. His dedication to advancing medical technology through research and collaboration is commendable and continues to inspire future inventors in the field.

This text is generated by artificial intelligence and may not be accurate.